検索結果 - Scott R. Plotkin

結果の絞り込み
  1. 1
    Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis

    Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis 著者: Jaishri O. Blakeley, Scott R. Plotkin

    出版事項 2016
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  2. 2
    Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1

    Increased Risk of Cerebrovascular Disease Among Patients With Neurofibromatosis Type 1 著者: Anna R. Terry, Justin T. Jordan, Lee H. Schwamm, Scott R. Plotkin

    出版事項 2015
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  3. 3
    Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature

    Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature 著者: Ana-Maria Vranceanu, Vanessa L. Merker, Elyse R. Park, Scott R. Plotkin

    出版事項 2013
    全文の入手
    Revisão
    お気に入りに追加
    保存先:
  4. 4
    Exacerbation of Cerebral Radiation Necrosis by Bevacizumab

    Exacerbation of Cerebral Radiation Necrosis by Bevacizumab 著者: Deva S. Jeyaretna, William T. Curry, Tracy T. Batchelor, Anat Stemmer‐Rachamimov, Scott R. Plotkin

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  5. 5
    Glioblastoma care in the elderly

    Glioblastoma care in the elderly 著者: Justin T. Jordan, Elizabeth R. Gerstner, Tracy T. Batchelor, Daniel P. Cahill, Scott R. Plotkin

    出版事項 2015
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  6. 6
    Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients

    Natural History of Vestibular Schwannoma Growth and Hearing Decline in Newly Diagnosed Neurofibromatosis Type 2 Patients 著者: Scott R. Plotkin, Vanessa L. Merker, Alona Muzikansky, Fred G. Barker, William H. Slattery

    出版事項 2013
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  7. 7
    Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients

    Clinical Features of Schwannomatosis: A Retrospective Analysis of 87 Patients 著者: Vanessa L. Merker, Sonia Esparza, Miriam J. Smith, Anat Stemmer‐Rachamimov, Scott R. Plotkin

    出版事項 2012
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  8. 8
    Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study

    Outcomes of hospitalization in pregnant women with CNS neoplasms: a population-based study 著者: Anna R. Terry, Fred G. Barker, Lisa Leffert, Brian T. Bateman, Irene Souter, Scott R. Plotkin

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  9. 9
    Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients

    Erlotinib for Progressive Vestibular Schwannoma in Neurofibromatosis 2 Patients 著者: Scott R. Plotkin, Chris Halpin, Michael J. McKenna, Jay S. Loeffler, Tracy T. Batchelor, Fred G. Barker

    出版事項 2010
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  10. 10
    Expression of SMARCB1 (INI1) mutations in familial schwannomatosis

    Expression of SMARCB1 (INI1) mutations in familial schwannomatosis 著者: Miriam J. Smith, James A. Walker, Yiping Shen, Anat Stemmer‐Rachamimov, James F. Gusella, Scott R. Plotkin

    出版事項 2012
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  11. 11
    Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome

    Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome 著者: Daphne L. Wang, Kelly B. Smith, Sonia Esparza, Fawn A. Leigh, Alona Muzikansky, Elyse R. Park, Scott R. Plotkin

    出版事項 2012
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  12. 12
    Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2

    Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2 著者: Scott R. Plotkin, Vanessa L. Merker, Chris Halpin, Dominique Jennings, Michael J. McKenna, Gordon J. Harris, Fred G. Barker

    出版事項 2012
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  13. 13
    Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2

    Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2 著者: Said Farschtschi, Vanessa L. Merker, David S. Wolf, Martin U. Schuhmann, Jaishri O. Blakeley, Scott R. Plotkin, Christian Hagel, Victor F. Mautner

    出版事項 2015
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  14. 14
    NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth

    NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth 著者: Marianne F. James, Sangyeul Han, Carolyn Polizzano, Scott R. Plotkin, Brendan D. Manning, Anat Stemmer‐Rachamimov, James F. Gusella, Vijaya Ramesh

    出版事項 2009
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  15. 15
    Achieving consensus for clinical trials

    Achieving consensus for clinical trials 著者: Scott R. Plotkin, Jaishri O. Blakeley, Eva Dombi, Michael J. Fisher, C. Oliver Hanemann, Karin S. Walsh, Pamela L. Wolters, Brigitte C. Widemann

    出版事項 2013
    全文の入手 全文の入手
    Revisão
    お気に入りに追加
    保存先:
  16. 16
    Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate

    Treatment of Relapsed Central Nervous System Lymphoma with High-Dose Methotrexate 著者: Scott R. Plotkin, Rebecca A. Betensky, Fred H. Hochberg, Stuart A. Grossman, Glenn J. Lesser, Burt Nabors, Brian H. Chon, Tracy T. Batchelor

    出版事項 2004
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  17. 17
    Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors

    Anti–Vascular Endothelial Growth Factor Therapies as a Novel Therapeutic Approach to Treating Neurofibromatosis-Related Tumors 著者: Hon Kit Wong, Johanna Lahdenranta, Walid S. Kamoun, Annie W. Chan, Andrea I. McClatchey, Scott R. Plotkin, Rakesh K. Jain, Emmanuelle di Tomaso

    出版事項 2010
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  18. 18
    Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis

    Relationship between whole‐body tumor burden, clinical phenotype, and quality of life in patients with neurofibromatosis 著者: Vanessa L. Merker, Miriam A. Bredella, Wenli Cai, Ara Kassarjian, Gordon J. Harris, Alona Muzikansky, Rosa Nguyen, Victor F. Mautner, Scott R. Plotkin

    出版事項 2014
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  19. 19
    Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey

    Self-reported access to specialty clinics and receipt of health surveillance among U.S. patients with neurofibromatosis 1: a national survey 著者: Vanessa L. Merker, Yidan Ma, Lori B. Chibnik, Heather B. Radtke, Kate Kelts, Kaleb Yohay, Nicole J. Ullrich, Scott R. Plotkin, Justin T. Jordan

    出版事項 2025
    全文の入手
    Artigo
    お気に入りに追加
    保存先:
  20. 20
    Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial

    Use of Video to Facilitate End-of-Life Discussions With Patients With Cancer: A Randomized Controlled Trial 著者: Areej El‐Jawahri, Lisa Podgurski, April F. Eichler, Scott R. Plotkin, Jennifer S. Temel, Susan L. Mitchell, Yuchiao Chang, Michael J. Barry, Angelo E. Volandes

    出版事項 2009
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: